Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | 1 | — | — |
After taking the Pfizer booster shot, I was diagnosed with Parkinson's; This is a spontaneous report received from a Consumer or other non HCP. A 79-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (BNT162B2 OMICRON (KP.2)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "High Blood Pressure" (unspecified if ongoing); "Vascular Disease" (unspecified if ongoing); "Dementia" (unspecified if ongoing); "Alzheimer's" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN; LANTUS; ATORVASTATIN; LISINOPRIL. Vaccination history included: Covid-19 vaccine (Primary immunisaton completed; Manufacturer unknown), for COVID-19 immunisation. The following information was reported: PARKINSON'S DISEASE (disability, medically significant), outcome "not recovered", described as "After taking the Pfizer booster shot, I was diagnosed with Parkinson's". Therapeutic measures were taken as a result of parkinson's disease. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Alzheimer's disease; Blood pressure high; Dementia; Diabetes; Vascular disorder
METFORMIN; LANTUS; ATORVASTATIN; LISINOPRIL